These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
43 related articles for article (PubMed ID: 3169225)
1. Sarcoidosis and acquired type II-b hyperlipoproteinaemia. Umeki S; Niki Y; Soejima R Eur Respir J; 1988 Jun; 1(6):558-9. PubMed ID: 3169225 [TBL] [Abstract][Full Text] [Related]
2. Alterations in serum lipid concentrations before and after myocardial infarction in a patient with hyperlipoproteinemia and sarcoidosis--a case report. Umeki S Angiology; 1988 Apr; 39(4):390-3. PubMed ID: 3364806 [TBL] [Abstract][Full Text] [Related]
3. [Effects of fenofibrate in four types of hyperlipoproteinaemia and on apoproteins A and B in type IIa HLP (author's transl)]. Micheli H; Pometta D; Gustafson A Nouv Presse Med; 1980 Dec; 9(49):3759-62. PubMed ID: 7208343 [TBL] [Abstract][Full Text] [Related]
4. [A case of Heerfordt's syndrome associated with acquired type II-b hyperlipoproteinemia, leading to the development of myocardial infarction during its clinical course]. Umeki S; Yagi S; Soejima R Nihon Kyobu Shikkan Gakkai Zasshi; 1988 Aug; 26(8):881-7. PubMed ID: 3204870 [No Abstract] [Full Text] [Related]
5. Increased plasma fibrinogen and platelet-aggregates in type II hyperlipoproteinaemia. Lowe GD; Drummond MM; Third JL; Bremner WF; Forbes CD; Prentice CR; Lawrie TD Thromb Haemost; 1980 Feb; 42(5):1503-7. PubMed ID: 7368154 [TBL] [Abstract][Full Text] [Related]
6. [Apolipoprotein E and activity of cholesterol esters transport in type IIA and IIB hyperlipoproteinemia]. Tvorogova MG; Rozhkova TA; Semenova OA; Lupanov VP; Nuraliev EIu ; Kukharchuk VV; Titov VN Ter Arkh; 1997; 69(12):30-3. PubMed ID: 9503530 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of ciprofibrate in primary type II and IV hyperlipidemia: the Italian multicenter study. Cattin L; Da Col PG; Feruglio FS; Finazzo L; Rimondi S; Descovich G; Manzato E; Zambon S; Crepaldi G; Siepi D Clin Ther; 1990; 12(6):482-8. PubMed ID: 2289217 [TBL] [Abstract][Full Text] [Related]
8. Reversible increase of the apo CII/apo CIII-1 ratio in the very low density lipoproteins after procetofen treatment in hypertriglyceridemic patients. Franceschini G; Sirtori M; Gianfranceschi G; Frosi T; Montanari G; Sirtori CR Artery; 1985; 12(6):363-81. PubMed ID: 4051756 [TBL] [Abstract][Full Text] [Related]
9. [The combination of psoriasis with different types of lipoproteinemias. 2. The characteristics of the dyslipoproteinemias caused by disorders in triacylglyceride transport in psoriasis]. Keshileva ZB; Kosukhin AB; Polevaia LG Vestn Dermatol Venerol; 1990; (5):7-11. PubMed ID: 2402946 [TBL] [Abstract][Full Text] [Related]
10. Very low density lipoprotein (VLDL) pattern in primary hyperlipoproteinaemia type IIb and type IV. Kłosiewicz-Latoszek L; Naruszewicz M; Cybulska B; Szostak WB; Chotkowska E Mater Med Pol; 1979; 11(3):230-4. PubMed ID: 232894 [No Abstract] [Full Text] [Related]
11. Lipid results of partial ileal bypass in patients with heterozygous, type II-A hyperlipoproteinemia. Program on the Surgical Control of the Hyperlipidemias. Campos CT; Matts JP; Fitch LL; Speech JC; Long JM; Buchwald H Surgery; 1990 Oct; 108(4):601-10; discussion 610-1. PubMed ID: 2120785 [TBL] [Abstract][Full Text] [Related]
12. Treatment of hyperlipoproteinemia, types II and IV, with pirifibrate: one hundred observations. Bonora V; Calalabuig RJ; Caviola E; Soler J; Pueyo JM; Micaló T; Cano RP Clin Ther; 1981; 4(3):192-200. PubMed ID: 7030489 [TBL] [Abstract][Full Text] [Related]
13. Unusual xanthomas in a young patient with heterozygous familial hypercholesterolemia and type III hyperlipoproteinemia. Feussner G; Dobmeyer J; Nissen H; Hansen TS Am J Med Genet; 1996 Oct; 65(2):149-54. PubMed ID: 8911609 [TBL] [Abstract][Full Text] [Related]
14. Fenofibrate and cholestyramine in type II hyperlipoproteinaemia. Lehtonen A; Viikari J Artery; 1982; 10(5):353-67. PubMed ID: 7181678 [TBL] [Abstract][Full Text] [Related]
15. [Composition of VLDL, LDL and HDL lipoprotein fractions in type IIa, IIb, III, IV, and V hyperlipemia patients in comparison with healthy individuals]. Hutt V; Klör HU; Wechsler JG; Ditschuneit H J Clin Chem Clin Biochem; 1984 Feb; 22(2):141-6. PubMed ID: 6716054 [TBL] [Abstract][Full Text] [Related]
16. [Platelet half-life in patients with primary hyperlipoproteinemia type IIa, IIb, and IV according to Fredrickson with and without clinical signs of atherosclerosis]. Jäger E; Sinzinger H; Widhalm K; Kaliman J; Höfer R Wien Klin Wochenschr; 1982 Sep; 94(16):421-5. PubMed ID: 7147981 [TBL] [Abstract][Full Text] [Related]
17. Clinical features of ischaemic heart disease correlated with high density lipoprotein cholesterol levels in men with hyperbetalipoproteinaemia. Nye ER; Robertson MC; Sutherland WH N Z Med J; 1984 Jul; 97(759):437-42. PubMed ID: 6589538 [TBL] [Abstract][Full Text] [Related]
18. A two-year study on the efficacy and tolerability of policosanol in patients with type II hyperlipoproteinaemia. Canetti M; Moreira M; Mas R; Illnait J; Fernandez L; Fernandez J; Diaz E; Castano G Int J Clin Pharmacol Res; 1995; 15(4):159-65. PubMed ID: 8871266 [TBL] [Abstract][Full Text] [Related]
19. Effects of oxandrolone on plasma lipoproteins in patients with type IIa, IIb and IV hyperlipoproteinemia: occurrence of hypo-high density lipoproteinemia. Tamai T; Nakai T; Yamada S; Kobayashi T; Hayashi T; Kutsumi Y; Takeda R Artery; 1979 Feb; 5(2):125-43. PubMed ID: 231951 [TBL] [Abstract][Full Text] [Related]
20. [Familial occlusion of central veins associated with type II familial hyperlipoproteinemia]. Castella A; Othenin-Girard P Klin Monbl Augenheilkd; 1992 May; 200(5):346-8. PubMed ID: 1614098 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]